Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website

Supernus Pharmaceuticals

Supernus Pharmaceuticals reported $1.81B in Market Capitalization this May of 2023, considering the latest stock price and the number of outstanding shares.

Market Capitalization Change
Abbott ABT:US USD 176.09B 15.34B
ANI Pharmaceuticals ANIP:US USD 715M 12M
Aurora Cannabis Inc ACB:CN CAD 320.53M 54.96M
Bristol-Myers Squibb BMY:US USD 145.78B 7.2B
Canopy Growth Corp WEED:CN CAD 1.21B 293.06M
Cara Therapeutics CARA:US USD 265M 312M
Corcept Therapeutics CORT:US USD 2.34B 151M
Eisai 4523:JP JPY 2.23T 319.01B
Eli Lilly LLY:US USD 327.06B 20.56B
Endo International ENDP:US USD 17M 0
Horizon Pharma HZNP:US USD 24.93B 895M
Marinus Pharmaceuticals MRNS:US USD 343M 145M
Pacira PCRX:US USD 1.88B 103M
Perrigo PRGO:US USD 4.85B 256M
Pfizer PFE:US USD 230.29B 57.33B
Revance Therapeutics RVNC:US USD 2.7B 1.18B
Supernus Pharmaceuticals SUPN:US USD 1.97B 42M
United Therapeutics UTHR:US USD 10.44B 2.23B
Xeris Pharmaceuticals Inc XERS:US USD 224M 43M